Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp. - PE Ratioverified

MDNA.TO

Price:

$0.4

Market Cap:

$31.05M

Medicenna Therapeutics Corp. is an immunotherapy firm focused on creating and commercializing Superkines and "empowered Superkines" to combat cancer and various other illnesses. Their primary candidate, MDNA55, an interleukin-4 (IL-4) empowered cytokine, has successfully finished Phase IIb trials for recurrent glioblastoma and is also being investigated for other brain and non-brain tumor types in earlier developmental stages. The company's pipeline also includes MDNA11, an improved IL-2 variant designed to stimulate immune responses against cancer; MDNA209, an IL-2 antagonist aimed at autoimmune conditions like multiple sclerosis and graft-versus-host disease; MDNA413, a dual IL-4/IL-13 ant...[Read more]

Industry

Biotechnology

IPO Date

2017-03-08

Stock Exchange

TSX

Ticker

MDNA.TO

The PE Ratio as of August 2026 (TTM) for Medicenna Therapeutics Corp. (MDNA.TO) is -1.82

According to Medicenna Therapeutics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -1.82. This represents a change of -52.40% compared to the average of -3.82 of the last 4 quarters.

Medicenna Therapeutics Corp. (MDNA.TO) Historical PE Ratio (quarterly & annually)

How has MDNA.TO PE Ratio performed in the past?

The mean historical PE Ratio of Medicenna Therapeutics Corp. over the last ten years is -2.74. The current -1.82 PE Ratio has changed 6.55% with respect to the historical average. Over the past ten years (40 quarters), MDNA.TO's PE Ratio was at its highest in in the March 2025 quarter at 16.12. The PE Ratio was at its lowest in in the June 2020 quarter at -25.05.

Quarterly (TTM)
Annual

Average

-2.74

Median

-5.71

Minimum

-14.60

Maximum

36.82

Medicenna Therapeutics Corp. (MDNA.TO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medicenna Therapeutics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 227.94%

Maximum Annual PE Ratio = 36.82

Minimum Annual Increase = -1037.24%

Minimum Annual PE Ratio = -14.60

Quarterly (TTM)
Annual
YearPE RatioChange
2026-2.91-55.47%
2025-6.5333.55%
2024-4.89-113.29%
202336.82-1037.24%
2022-3.93-73.09%
2021-14.605.44%
2020-13.85227.94%
2019-4.22-35.84%
2018-6.58-1.29%
2017-6.67-79.41%

Medicenna Therapeutics Corp. (MDNA.TO) Average PE Ratio

How has MDNA.TO PE Ratio performed in the past?

The current PE Ratio of Medicenna Therapeutics Corp. (MDNA.TO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.78

5-year avg

3.71

10-year avg

-2.74

Medicenna Therapeutics Corp. (MDNA.TO) PE Ratio vs. Peers

How is MDNA.TO’s PE Ratio compared to its peers?

Medicenna Therapeutics Corp.’s PE Ratio is greater than BioNxt Solutions Inc. (-4.06), less than Satellos Bioscience Inc. (-1.75), greater than MedMira Inc. (-13.64), greater than Defence Therapeutics Inc. (-3.40), less than Planet 13 Holdings Inc. (-0.65), greater than Arch Biopartners Inc. (-27.55), greater than Zentek Ltd. (-9.89), greater than Sernova Corp. (-3.13), less than Covalon Technologies Ltd. (39.61), greater than Medexus Pharmaceuticals Inc. (-49.60),

Build a custom stock screener for Medicenna Therapeutics Corp. (MDNA.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medicenna Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medicenna Therapeutics Corp. (MDNA.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medicenna Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medicenna Therapeutics Corp.'s PE Ratio?

How is the PE Ratio calculated for Medicenna Therapeutics Corp. (MDNA.TO)?

What is the highest PE Ratio for Medicenna Therapeutics Corp. (MDNA.TO)?

What is the 3-year average PE Ratio for Medicenna Therapeutics Corp. (MDNA.TO)?

What is the 5-year average PE Ratio for Medicenna Therapeutics Corp. (MDNA.TO)?

How does the current PE Ratio for Medicenna Therapeutics Corp. (MDNA.TO) compare to its historical average?